Holocene Advisors, LP Intellia Therapeutics, Inc. Transaction History

Holocene Advisors, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$58.27 - $118.99 $18.4 Million - $37.7 Million	-316,576 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$100.76 - $138.36 $6.75 Million - $9.27 Million	67,030 Added 26.86%	316,576 $37.4 Million
Q3 2021 Nov 15, 2021	BUY	$132.37 - $176.78 $8.41 Million - $11.2 Million	63,511 Added 34.14%	249,546 $33.5 Million
Q2 2021 Aug 16, 2021	SELL	$60.88 - $161.91 $21.9 Million - $58.3 Million	-359,977 Reduced 65.93%	186,035 $30.1 Million
Q1 2021 May 17, 2021	BUY	$46.59 - $83.68 $4.5 Million - $8.08 Million	96,617 Added 21.5%	546,012 $43.8 Million
Q4 2020 Feb 16, 2021	BUY	$18.83 - $63.53 $8.46 Million - $28.6 Million	449,395 New	449,395 $24.4 Million

314

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $926M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.